DEBUG THERAPEUTICS
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Manufacture of pharmaceutical preparations (21.20Z)
- Sector
- Manufacture of basic pharmaceutical products and pharmaceutical preparations
- Headcount
- Headcount unknown
- Created
- 25 Jul 2022
- Share capital
- 7,000.00 EUR
- Registered with the trade register
- 18 Aug 2022
- Financial year end
- 31/12
- Establishments
- 1
Directors
- PETER HEBBELN 53 years old, 02/1973 Directeur general
- CLAIRE SOPHIE STOECKLE 51 years old, 05/1975 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- STOECKLI via CLAIRE SOPHIE STOECKLE
Other companies at the same address
3 other company head offices are registered at this address.
Establishments
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
69 / 100 B
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (4.3 years)
- 8.7 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Legal notices
-
Filing of accounts 6 Oct 2026
- Court :
- Greffe du Tribunal Judiciaire de colmar
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260191, annonce n 9635 · Proof of publication (PDF)
-
Filing of accounts 9 Jul 2026
- Court :
- Greffe du Tribunal Judiciaire de colmar
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20260129, annonce n 11881 · Proof of publication (PDF)
-
Filing of accounts 9 Jul 2026
- Court :
- Greffe du Tribunal Judiciaire de colmar
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20260129, annonce n 11882 · Proof of publication (PDF)
-
Incorporation 7 Sep 2022
- Court :
- Greffe du Tribunal d'Instance de Colmar
BODACC A n 20220173, annonce n 922 · Proof of publication (PDF)
Filings and annual accounts as PDF →
Change history
- Appointed: President de SAS 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Share capital: 7,000 € 3 Oct 2026
Frequently asked questions about DEBUG THERAPEUTICS
- What is the SIREN number of DEBUG THERAPEUTICS?
- The SIREN number of DEBUG THERAPEUTICS is 918458522. Its intra-community VAT number is FR77918458522.
- Where is the head office of DEBUG THERAPEUTICS?
- Head office address: 17 RUE DE VERDUN, 68000 COLMAR.
- When was DEBUG THERAPEUTICS founded?
- DEBUG THERAPEUTICS was founded on 25 Jul 2022.
- What does DEBUG THERAPEUTICS do?
- Its declared main activity is: Manufacture of pharmaceutical preparations (NAF code 21.20Z).
- Who runs DEBUG THERAPEUTICS?
- The officers listed in the register are PETER HEBBELN (Directeur general), CLAIRE SOPHIE STOECKLE (President de SAS).
- Is DEBUG THERAPEUTICS subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.